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Background. Proliferation and differentiation of the endometrium are regulated by estrogen and
progesterone. The enormous regenerative capacity of the endometrium is thought to be based
on the activity of adult stem cells. However, information on endocrine regulatory mechanisms in
human endometrial stem cells is scarce. In the present study, we investigated the expression of
ERα,E R β, and PR in clonal cultures of human endometrial stem cells derived from transcervical
biopsies. Methods. Endometrial tissue of 11 patients was obtained by transcervical biopsy.
Stromal cell suspensions were plated at clonal density and incubated for 15 days. Expression of
ERα,E R β and PR was determined by qPCR prior to and after one cloning round, and normalized
to 18S rRNA expression. Results. Expression of ERα and ERβ was downregulated by 64% and
89%, respectively (P = 0.002 and P < 0.001). In contrast, PR was not signiﬁcantly downregulated,
due to a more heterogenous expression pattern. Conclusions. Culture of human endometrial
stroma cells results in a downregulation of ERα and ERβ, while expression of PR remained un-
changed in our patient collective. These results support the hypothesis that stem cells may not be
subject to direct stimulation by sex steroids, but rather by paracrine mechanisms within the stem
cell niche.
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1. INTRODUCTION
1.1. Stem Cells in the Endometrium
Stem cells havebeenlong thoughtto participate in the physiologicalfunction of the endometrium providing
the basis for monthly remodeling during the reproductive phase of women [1]. This view is not only sup-
ported by ﬁndings of a clonal origin of endometrial glands and cultured endometrial cells [2–4], but also by
the demonstrationof stem-cell markergene expression,including pluripotency-associatedtranscription fac-
tors such as Oct4, nanog, KLF4, and Sox2 [4, 5] and adult stem-cell markers such as CD146, CD73, CD90,
notch1, and Msi1 [1, 6–8]. Mesenchymal stem-cell properties of endometrial cells were also demonstrated
based on multilineage differentiation potential both in vitro and in murine models [8, 9]. Finally, bone-
marrow transplantation experiments between HLA-, or sex-mismatcheddonors and recipients strongly sug-
gest that bone-marrow-derived stem cells can reconstitute both stroma and glands of the human endome-
trium [10, 11].
1.2. Stem-Cell Involvement in Endometrial Pathologies
Based on their speciﬁc properties, including unlimited proliferative potential, high expression of multidrug-
resistanceproteins,andhigh developmentalplasticity,it isnotsurprisingthatadysregulationofendometrial
stem-cellfunctionmayberelatedtothepathogenesisofproliferativediseasesoftheendometrium,including
endometriosis, endometrial hyperplasia, or endometrial carcinoma [12, 13]. For example, our group could
recently demonstrate an upregulation of putative endometrial stem-cell numbers expressing the adult stem-
cellmarkersMsi1inendometriosisandendometrialcarcinoma[7].Similarly,expressionofthepluripotency
factors Sox2 and Oct4 is dysregulatedin endometriosis [4, 14]. siRNA-mediated downregulationof Msi1 in
vitro led to a downregulationof notch-signalingpathway componentsand induced apoptosisin endometrial
carcinoma cells, demonstrating the relevance of cancer stem cells for endometrial carcinoma pathogenesis
[13]. Further evidence for the presence of cancer stem cells in endometrial carcinoma was provided by the
demonstration of a contribution of endometrialside populationcells to epithelial-to-mesenchymaltransition
inendometrialcarcinoma[15]andbyxenograftstudiesdemonstratingcancerstem-cellactivityofclonalen-
dometrial cultures isolated from human endometrial carcinoma biopsies [16].
1.3. Stem Cell Niche and Hormone Dependency
Stem cells are hypothesizedto reside in a niche, constituting a microenvironment which keeps the stem cell
in an undifferentiated state and allows for activation and differentiation of stem and progenitor cells only
under controlled conditions when regeneration and proliferation of the tissue is required [17, 18]. There-
fore, pathological alterations of the niche could be part of the mechanism leading to endometriosis or oth-
er conditions depending on abnormal endometrial proliferation. The niche is not well characterized yet,
but it was hypothesized that it was hormone dependent [19]. This is supported by the fact that endome-
trium proliferates underestrogeninﬂuenceandprogesteronewill causea secretorystate, whileprogesterone
withdrawal will lead to shedding of the endometrium, resulting in menses. In addition, endocrine dysregu-
lation playsamajorrole in endometrialpathologies,includingforexample,progesteroneresistancein endo-
metriosis [20] or hormone-dependent proliferation of endometrial carcinoma [21, 22]. After injury of
the murine endometrium, an increase of side population cells was recently observed, which are proba-
bly involved in tissue repair [23]. In this study, in ovariectomized mice, estrogen played a critical role: im-
plantation of estradiol pellets restored the increase ofside population cells after endometrialtissue injury by
peritoneal injection of lipopolysaccharide. It was concluded that estrogen probably stimulated endometrial
regeneration by stimulating stem-cell proliferation [23]. In a different mouse model, endometrial epithelial
label retaining cells (LRCs)—a surrogate marker of slow cycling stem cell activity—lacked the expression
of estrogen receptor, whereas a small proportion of stromal LRCs expressed estrogen receptor 1 [19]. It
was hypothesized that this population of subepithelial stromal LRCs constitutes part of the stem-cell niche,
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conveying estrogen-driven proliferation of epithelial LRCs via paracrine pathways. However, surprisingly,
to date, information on the structure of the human endometrial stem-cell niche and its hormone dependency
is still scarce. This led us to investigate the expression of ERα,E R β, and progesterone receptor (PR) in
clonal stem-cell cultures obtained from human endometrial biopsies, which had previously been shown to
display mesenchymalstem-cell properties [8].
2. MATERIAL AND METHODS
2.1. Patients and Endometrial Samples
Endometrial samples of eleven female patients undergoing pretreatment diagnostics in the reproductive
medicine unit of the university hospital were studied. All patients gave written informed consent to this
study, which was approved by the local ethics commission (no. 2008-223-f-S) and which was carried out
according to the principles of the Helsinki Convention. Transcervical endometrial biopsies were taken on
the 22nd to 24th cycle day as part of the diagnostic routine and conducted as published before [8]. Brieﬂy,
after cleansing of the vagina with moist sponges a Probet catheter (Gynemed, Lensahn, Germany) was
inserted through the nondilated cervical canal. Upon reaching the uterine cavity, the plunger was retracted,
and the device was moved forwards and backwards while rotating. Samples were split in two, and one
part was analyzed by the pathologist according to established criteria [24], while the remaining part was
transferred in HEPES-buffered Dulbecco modiﬁed Eagle medium/Hams F-12 (DMEM/F-12, Invitrogen,
Carlsbad, Calif, USA).
2.2. Isolation of Endometrial Stromal Cells
Isolation of endometrial stromal cells from endometrial biopsies was performed as described before [8].
Brieﬂy, endometrial tissue was enzymatically dissociated by incubation with 300μg/mL collagenase III
(Biochrom, Berlin, Germany) and 40μg/mL DNAse I (Roche Diagnostics, Mannheim, Germany) for 45–
60min, followed by a 1:10 dilution of the digest in PBS/10% FCS and a removal of debris and epithelial
cell sheets using a 40μm cell strainer (Falcon). Stromal cells were obtained using magnetic Dynabeads
(Dynal Biotech, Oslo, Norway) coated with speciﬁc antibodies for epithelial cells (BerEP4) and leukocytes
(CD45) as essentially described by Chan et al. [25]. Following erythrocyte lysis, the cells were resuspended
in DMEM/F-12/10% FCSmediumandseededonﬁbronectin-coated60-mm Petri dishes(BectonDickinson
Biosciences, Bedford, Mass, USA) at a density of 630cells/3mL for serial cloning. Cells were cultured in
a humidiﬁed incubator at 37◦Ci na5 %C O 2 atmosphere. Clonal density cultures were cultured for 15 days,
while the remainder of the cells was cultured for 24h after isolation and served as a control.
2.3. Quantitative Real-Time PCR (qPCR) Analysis
qPCRwasusedtoanalysetheclonalstromalcellsfortheexpressionofestrogenreceptoralpha(ERα), estro-
gen receptor beta (ERβ), and progesterone receptor (PR). RNA- and cDNA-preparation and qPCR were
performed exactly as previously described using the TaqMan gene expression systems hs00174860 m1,
hs00230957 m1, and hs001556702 m1 (Applied Biosystems) (see http://www.allgenes.com/ for sequence
information). Target gene expression was normalized to 18S rRNA (Hs99999901 s1). Relative quantitation
was performed using the comparativecycle threshold method [26]. Statistical analysis was performed using
Student’s t-test. A P value of <0.05 was considered statistically signiﬁcant.
3. RESULTS
Elevenendometrial samples were included in the study, a characterization of the respectivepatients is given
in Table 1. All samples were obtained in a secretory phase with a mean serum progesterone concentration
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TABLE 1: Clinical characteristics of patients and change of hormone receptor expression after the ﬁrst
cloning round.
Patient Age
(yrs) BMI Mis-
carriages Cycle phase Histological
cycle day
Progesterone
(ng/mL) ERα FC ERβ
FC PR FC ERβ/ERα
control
ERβ/ERα 1st
cloning round
HA 25 21 0 Secretory 23 11.02 0.002 0.016 0.036 0.0151 0.1199
LK 36 19 1 Secretory 16 13.48 0.265 0.011 0.130 0.0090 0.0004
LM 36 18 0 Secretory 23 15.00 0.281 0.008 0.607 0.1490 0.0040
HM 29 25 0 Secretory 22 8.37 0.299 0.357 0.139 0.0047 0.0057
IV 24 18 1 Secretory 17 18.00 0.271 0.329 0.318 0.0082 0.0100
YA 26 24 0 Secretory 22 14.61 0.002 0.009 0.035 0.0037 0.0206
HI 38 23 3 Secretory 21 17.03 0.012 0.004 0.036 0.0124 0.0044
WS 29 34 0 Secretory 23 9.43 0.008 0.037 0.022 0.0059 0.0252
BN 35 29 3 Secretory 23 16.79 0.220 0.080 1.530 0.2645 0.0959
LF 42 25 0 Secretory 23 12.16 1.632 0.048 5.249 0.0054 0.0002
CM 32 23 1 Secretory 17 14.61 1.010 0.363 1.302 0.0005 0.0002
FC: fold change of hormone receptor expression after the ﬁrst cloning round.
ER: estrogen receptor; PR: progesterone receptor.
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FIGURE 1:  Ct values relative to 18S rRNA expression of hormone receptor expression in endometrial
stroma cell cultures after the ﬁrst cloning round. Please note that a higher  Ct value corresponds to a
comparably lower expression level. Error bars = SEM, n = 11.
of13.68(8.37–17.03)ng/mL.Accordingly,endometrialdatingcorrespondedwithameancycledayof20.59
(16–23). After obtaining endometrial biopsies,stromal cells were preparedas describedpreviously[8]. One
aliquot of the cells was cultured over night at high density to obtain a control cell culture. A second aliquot
wasplatedatclonaldensityandculturedfor15daysin ordertoobtain astem-cell-enrichedculture. Wehave
previously shown that expression of stem-cell markers such as CD146 is signiﬁcantly enriched after serial
cloning and that serially passaged long-term cultures have mesenchymal stem-cell-(MSC-) like properties
[8]. A qPCR analysis of hormone receptor expression revealed that based on the average  Ct values of
control cell cultures, ERα and PR were expressed at similar mRNA-levels, whereas ERβ expression was
about 100-fold lower (Figure 1). Comparing the group as a whole, endometrial MSCs of clonal cultures
signiﬁcantly downregulated expression of ERα und ERβ after the ﬁrst cloning round (P < 0.01 and P <
0.001, resp.) (Table 1, Figures 1 and 2). However, down-regulation of PR was not signiﬁcant for the whole
group, caused by up regulation of PR in two patients (BN, LF) and no change of expression in another
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FIGURE 2: Fold change of hormone receptor expression in endometrial stroma cell cultures after the ﬁrst
cloning round. Error bars = SEM, n = 11, ∗∗ = P < 0.01, ∗∗∗=P < 0.001.
patient (CM). Notably, in two of these patients with differing PCR results for change of PR expression,
expression of ERα was upregulated (LF) or not changed (CM) after the ﬁrst cloning round. Considering
clinical parameters of the three subjects with differing PCR results, a nonsigniﬁcant trend towards higher
age (36.3 versus 30.4), higher BMI (25.7 versus 22.7), and higher number of miscarriages (1.3 versus 0.6)
was found compared with individuals displaying a downregulation of ERα,E R β, and PR after the ﬁrst
cloning round. Information about the presence of endometriosis as assessed by laparoscopy was available
in four of the studied individuals: two patients with proof of endometriosis (BN, LK) and two patients
with exclusion of endometriosis (LM, LF) were equally distributed between groups. As an imbalance in the
ratio of ERβ to ERα expression has been linked to endometrial pathologies such as endometriosis [20], we
ﬁnally determined possible changes in this ratio linked to an enrichment of stem cells in our clonal stroma
cell cultures.Theratio ofendometrialERβ to ERα expressionprovedto behighly variablebetweenpatients
(Figure 3, Table 1). Consequently,no signiﬁcantdifference could be determined betweencontrol and clonal
stem-cell cultures.
4. DISCUSSION
In this paper, we report on the expression of ERα,E R β, and PR in human clonal endometrial stem-cell
cultures, ﬁnding a signiﬁcant downregulation of ERα and ERβ after the ﬁrst cloning round. Notably,
expression of PR remained unchanged for the whole group, caused by a varying expression pattern in indi-
vidual subjects. This study extends the presently limited information available on the putative role of sex-
ual steroids in endometrial stem cells, possibly involved in the unravelled structure and function of the hu-
man endometrial stem-cell niche. We and others have previously shown that serial cloning of endometrial
stromal cells obtained by minimally invasive transcervical biopsy leads to an enrichment of stem-cell
markers and to a multilineage differentiation potential [8, 27]. Stem cells have been hypothesized to be
involved in the cyclic growth and renewal of human endometrium, a tissue of high regenerative capacity
[28]. However, while estrogen and progesterone are well-known key endocrine players in the monthly pro-
liferation, differentiation, and shedding of the endometrium, data on stem cells and their role in endocrine
regulation of endometrial function is scarce.
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4.1. ERα
Our ﬁnding of a downregulation of ERα in human endometrial stem cells is in agreement with a report on
label retaining cells (LRCs) of the mouse endometrium, which downregulate ERα, supporting the concept
of stem cells as nondifferentiated entities lacking speciﬁc differentiation markers [19]. Supporting these
ﬁndings, the ﬁrst report on endocrine properties of endometrial stem cells in humans recently observed that
cellular suspensions of human endometrial side population cell lines lacked expression of ERα in either
epithelial stem-cell line (ICEp) or stromal stem-cell line (ICEs) [27].
4.2. PR
However, while in the latter studies expression of PR was also downregulated, the expression of PR in our
collective was unchanged after the ﬁrst cloning round. Notably, the lack of change in PR expression for the
whole group was caused by a distinct variability of PR expression, displaying an upregulation or no change
of expression in individual subjects. We can only speculate about this rather unexpected ﬁnding in some
of our clonal cell colonies. In a mouse model, a portion of stromal endometrial stem cells were capable of
expressing ERα, and it was speculated that these hormone responsive cells represent a part of the stem-cell
niche controlling proliferation of epithelial stem cells via paracrine pathways [19]. However, an increased
expression of PR in endometrial stem cells has not been reported to date [19, 27]. Because our endometrial
samples were obtained under standardized conditions in a luteal phase as conﬁrmed by progesterone serum
concentrationsand histological endometrial dating, the observedupregulation of PR in some of our patients
could support the hypothesis that our time point of sample acquisition has enriched these cells expressing
PR and that they reﬂect a phenotypictrait of the stem-cell niche presenting in secretory endometrium. From
the only other study to date investigating ERα and PR in human endometrial stem cells, no information
is available about the cycle phase in which endometrial biopsies were obtained [27]. While we can only
speculate about the relevance of our ﬁndings, evaluation of clinical parameters in patients with a differing
expression pattern of PR revealed a trend for conditions associated with endometrial malfunction such as
a higher age, a higher BMI, and an increased prevalence of miscarriages. It is, therefore, possible that our
collective included patients with an impaired endometrial function which led to an activation of the stem-
cell niche as proposed before [28]. Application of minimally invasive endometrial biopsies will allow for
the evaluation of a larger sample size in well-characterized subjects and help to clarify the role of stem cells
in endometrial pathology [8].
4.3. ERβ
For the ﬁrst time, we report on the change of ERβ mRNA-expression in human endometrial stem cells of
clonalcultures.Physiologically,ERβ isconsideredto exerta modulatingimpact onERα-mediatedendome-
trial responses,possibly promoting glandular differentiation [29]. Additionally, a possible pathological role
for ERβ in the etiology of endometriosis has recently emerged. In endometriotic tissue, an elevated ERβ to
ERα ratio was hypothesized to decrease PR expression, which could contribute to progesterone resistance,
a suspectedcausal factor for the developmentof endometriosis [20]. However, when ERβ to ERα ratio was
determined in ourendometrial stem-cellcultures, no signiﬁcantdifference could be observedin comparison
to controls.
5. CONCLUSION
In conclusion, our results are further proof for the presence of stem cells in human endometrium which can
beobtainedbyminimally invasivetranscervicalbiopsies,allowingforlarge-scalestudies.Thehere-reported
ﬁndings in clonal cultures support the concept of human endometrial stem cells downregulating expression
of ERα and ERβ. The novelﬁnding of a varying PR expressionin clonal cultures could help to characterize
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FIGURE 3: Ratio of ERβ-t oE R α-expression in endometrial stroma cell cultures after the ﬁrst cloning round.
Error bars = SEM, n = 11, P = n.s.
part of the unravelled stem-cell niche, which appears to convey the endocrine signal of sexual steroids to
stem cells byparacrinesignalways.Ourobservationsalsosuggestthatclinicalinformation aboutindividual
subjects may be of interest in future studies, promoting the evaluation of well-characterized populations
including endocrine and reproductive data associated with endometrial capacity.
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